Modulation of transforming growth factor β function in hepatocytes and hepatic stellate cells in rat liver injury

Gut

Volumn 46, Issue 5, 2000, Pages 719-724

  Date, M ^a   Matsuzaki, K ^a   Matsushita, M ^a   Tahashi, Y ^a   Furukawa, F ^a   Inoue, K ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Fibronectin; Hepatic stellate cell; Hepatocyte; Liver regeneration; TGF receptor

Indexed keywords

CARBON TETRACHLORIDE; FIBRONECTIN; LIGAND; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; IMMUNOMODULATION; LIVER CELL; LIVER INJURY; LIVER REGENERATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; STELLATE CELL;

ANIMALS; CARBON TETRACHLORIDE; CELL DIVISION; DNA; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRONECTINS; IODINE RADIOISOTOPES; LIVER; LIVER REGENERATION; MALE; RATS; RATS, WISTAR; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034023752     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.46.5.719     Document Type: Article

References (24)

1. 1 Massagué J. Transforming growth factor-β family. Annu Rev Cell Biol 1990;6:597-641.
2. 2 Barnard JA, Lyons RM, Moses HL. The cell biology of transforming growth factor β. Biochem Biophys Acta 1990;1032:79-87.
3. 3 Franzén P, ten Dijke P, Yamashita H, et al. Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor. Cell 1993;75:681-92.
4. 4 Lin HY, Wang X-F, Ng-Eaton E, et al. Expression cloning of the TGFβ type II receptor, a functional transmembrane serine/threonine kinase. Cell 1992;68:775-85.
5. 5 Wang X-F, Lin HY, Ng-Eaton E, et al. Expression cloning and characterization of the TGFβ type III receptor. Cell 1991;67:797-805.
6. 6 Attisano L, Wrana JL, López-Casillas F, et al. TGF-β receptors and actions. Biochem Biophys Acta 1994;1222:71-80.
7. 7 Heldin C-H, Miyazono K, ten Dijke P. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 1997;390:465-71.
8. 8 Bedosa P, Paradis V. Transforming growth factor-β (TGF-β): a key-role in liver fibrogenesis. J Hepatol 1995;22:37-42.
9. 9 Armendariz-Borunda J, Seyer JM, Kang AN, et al. Regulation of TGFβ gene expression in rat liver intoxicated with carbon tetrachloride. FASEB J 1990;4:215-21.
10. 10 Carr BI, Hayashi I, Branum EL, et al. Inhibition of DNA synthesis in rat hepatocytes by platelet derived type β transforming growth factor. Cancer Res 1986;46:2330-4.
11. 11 Russell WE, Coffey RJ, Ouellette AJ, et al. Type β transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci USA 1988;85:5126-30.
12. 12 Friedman SL. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993;328: 1828-35.
13. 13 Lindroos PM, Zarngar R, Michalopoulos GK. Hepatocyte growth factor (hepatoproietin) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated partial hepatectomy and tetrachloride administration. Hepatology 1991;13:743-9.
14. 4-induced acute damage or fibrosis. Biochem Biophys Acta 1993;1181:266-72.
15. 4 administration. J Hepatol 1998;28:572-81.
16. 16 Knook DL, Seffelaar AM, De Leeuw AM. Fat storing cells of the rat liver. Their isolation and purification. Exp Cell Res 1982;139:468-71.
17. 17 Saitoh M, Nishitoh H, Amagasa T, et al. Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways transforming growth factor-β. J Biol Chem 1996;271:2769-75.
18. 18 Matsuzaki K, Xu J, Wang F, et al. A widely expressed transmembrane serine/threonine kinase that does not bind activin, inhibin, transforming growth factor β, or bone morphogenic factor. J Biol Chem 1993;268:12719-23.
19. 19 Xu J, McKeehan K, Matsuzaki K, et al. Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism. J Biol Chem 1995;270:6308-13.
20. 20 Nakamura T, Tomita Y, Hirai R, et al. Inhibitory effect of transforming growth factor-β on DNA synthesis of adult rat hepatocytes in primary culture. Biochem Biophys Res Commun 1985;133:1042-50.
21. 21 Hautekeete ML, Geerts A. The hepatic stellate (Ito) cell: its role in human liver disease. Virchows Arch 1997;430:195-207.
22. 22 Ramadori G, Knittel T, Odenthal M, et al. Synthesis of cellular fibronectin by rat liver fat-storing (Ito) cells: regulation by cytokines. Gastroenterology 1992;103:1313-21.
23. 23 Bae HW, Geiser AG, Kim DH, et al. Characterization of the promoter region of the human transforming growth factor-β type II receptor gene. J Biol Chem 1995;270: 29460-8.
24. 24 Kim DH, Chang JH, Lee KH, et al. Mechanism of E1A-induced transforming growth factor-β (TGF-β) resistance in mouse keratinocytes involves repression of TGF-β type II transcription. J Biol Chem 1997;272: 688-94.